The global Non-Hodgkin Lymphoma (NHL) Therapeutics Market is set to expand significantly, growing from USD 8.26 billion in 2021 to USD 12.14 billion by 2030. This growth represents a compound annual growth rate (CAGR) of 8.4% during the forecast period. Factors contributing to this expansion include increasing cancer prevalence, advancements in treatment options, and the rising adoption of...